Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quality Assurance01:19

Quality Assurance

Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Papillomavirus Prevalence Among Australian Men Aged 18-35 Years in 2015-2018 According to Vaccination Status and Sexual Orientation.

The Journal of infectious diseases·2024
Same author

Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea.

The Lancet. Global health·2024
Same author

Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer.

Pathogens (Basel, Switzerland)·2023
Same author

Performance of Human Papillomavirus Attribution Algorithms to Predict Causative Genotypes in Anal High-Grade Lesions.

The Journal of infectious diseases·2023
Same author

Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).

The Lancet. Global health·2022
Same author

Correction to: Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2022

Related Experiment Video

Updated: Jun 10, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Quality assessment for human papillomavirus testing.

Sepehr N Tabrizi1

  • 1Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Australia. Sepehr.tabrizi@thewomens.org.au

Sexual Health
|August 20, 2010
PubMed
Summary
This summary is machine-generated.

Accurate human papillomavirus (HPV) testing requires laboratories to use quality assurance programs, including internal controls and external quality-assurance schemes (EQAS). Selecting appropriate testing panels is crucial for correct patient management and cost-effective treatment.

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Related Experiment Videos

Last Updated: Jun 10, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Area of Science:

  • Clinical diagnostics
  • Molecular biology
  • Public health

Background:

  • Numerous commercial and in-house assays exist for human papillomavirus (HPV) testing.
  • Laboratories must ensure the accuracy and reproducibility of HPV testing results.

Purpose of the Study:

  • To emphasize the importance of quality assurance in HPV testing.
  • To highlight the necessity of selecting appropriate testing panels for targeted HPV types.

Main Methods:

  • Implementing ongoing internal quality control measures.
  • Participating in available external quality-assurance schemes (EQAS).
  • Careful selection of EQAS panels aligned with the laboratory's HPV assay and targeted types.

Main Results:

  • Participation in EQAS is a mandatory requirement for laboratories performing HPV testing.
  • Appropriate panel selection ensures accurate detection of targeted HPV types.

Conclusions:

  • Robust quality assurance programs, including EQAS, are essential for reliable HPV testing.
  • Failure to select appropriate testing panels can negatively impact patient management and increase healthcare costs.